Semaglutide studies: 1,194 papers with results
Page 12 of 24
- Comparing medication persistence with oral and subcutaneous semaglutide in a real-world setting.
Conti M · Acta diabetologica · 2025
Observational study · 7 results
- Impact of oral semaglutide on serum urate levels in people with type 2 diabetes: A retrospective real-world analysis (URISEMA study).
Moreno-Pérez O · Seminars in arthritis and rheumatism · 2025
Observational study · 8 results
- Weight loss associated with semaglutide treatment among people with HIV.
Haidar L · AIDS (London, England) · 2024
Observational study · 2 results
- Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study.
Wolffenbuttel BHR · Advances in therapy · 2023
Observational study · 11 results
- Sleeve Gastrectomy Versus Semaglutide for Weight Loss in a Severely Obese Minority Cohort: A Propensity-Matched Study.
Masrur MA · Obesity surgery · 2025
Observational study · 2 results
- Real-World Use of Semaglutide for Weight Management: Dose Titration, Discontinuation Patterns and Weight Changes.
Skandov MD · Diabetes, obesity & metabolism · 2026
Observational study · 5 results
- Digital Engagement and Predictors of Semaglutide Persistence and Weight Loss in Severe Obesity: 48-Week Observational Study.
Tournayre S · Journal of medical Internet research · 2026
Observational study · 7 results
- Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity.
Ghusn W · JAMA network open · 2022
Observational study · 8 results
- Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study.
Rudofsky G · Diabetes research and clinical practice · 2021
Observational study · 7 results
- Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain.
Garcia de Lucas MD · Frontiers in endocrinology · 2022
Observational study · 9 results
- Real-world impact of oral semaglutide on inflammatory markers in patients at high cardiovascular risk.
Mariscal Vázquez S · Revista clinica espanola · 2026
Observational study · 5 results
- Endoscopic sleeve gastroplasty versus oral semaglutide for obesity: a real-world comparative cohort study.
Jagtap N · Endoscopy · 2026
Observational study · 6 results
- Weight Changes With Lower Doses of Semaglutide in Clinical Practice: Findings From the Chinese HARMONY Cohort.
Liu S · Diabetes, obesity & metabolism · 2026
Observational study · 5 results
- Semaglutide and Tirzepatide in a Remote Weight Management Program: 12-Month Retrospective Observational Study.
Richards R · JMIR formative research · 2025
Observational study · 12 results
- Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.
Spitery A · The American journal of managed care · 2026
Observational study · 14 results
- Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase.
Seijas-Amigo J · Primary care diabetes · 2023
Observational study · 15 results
- Changes in body weight and composition, metabolic parameters, and quality of life in patients with type 2 diabetes treated with subcutaneous semaglutide in real-world clinical practice.
Pantanetti P · Frontiers in endocrinology · 2024
Observational study · 14 results
- Semaglutide Plus Metformin Versus Metformin Alone For Antipsychotic-Induced Weight Gain In Patients With Type 2 Diabetes Mellitus.
Vu C · The Psychiatric quarterly · 2025
Observational study · 3 results
- Results of semaglutide in patients older than 70 years, a real-world study of efficacy and safety.
Garcia DE Lucas MD · Minerva endocrinology · 2025
Observational study · 4 results
- Semaglutide treatment for children with obesity: an observational study.
van Boxel EJ · Archives of disease in childhood · 2024
Observational study · 9 results
- Sequential Intragastric Balloon Followed By GLP-1 Receptor Agonist Therapy in Obesity: A Comparative Study of 12-Month Weight Loss Outcomes.
Teke E · Obesity surgery · 2026
Observational study · 5 results
- Evaluation of gastric content in fasting patient during semaglutide use: an observational study.
Queiroz VNF · Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2025
Observational study · 6 results
- Efficacy and safety of oral semaglutide in older patients with type 2 diabetes: a retrospective observational study (the OTARU-SEMA study).
Oe Y · BMC endocrine disorders · 2024
Observational study · 8 results
- Semaglutide in patients with kidney failure and obesity undergoing dialysis and wishing to be transplanted: A prospective, observational, open-label study.
Vanek L · Diabetes, obesity & metabolism · 2024
Observational study · 6 results
- Preliminary Real-World Experience with Semaglutide in Obese Patients with Type 2 Diabetes on Chronic Hemodialysis: A Multicenter Pilot Study.
Yugueros A · Medicina (Kaunas, Lithuania) · 2026
Observational study · 6 results
- Use of once-weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study.
Yale JF · Diabetes, obesity & metabolism · 2021
Observational study · 7 results
- SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.
Fu EL · BMJ (Clinical research ed.) · 2024
Observational study · 10 results
- Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real-world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World).
Smolderen KG · Diabetes, obesity & metabolism · 2025
Observational study · 10 results
- Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes.
Crisafulli S · Annals of internal medicine · 2026
Observational study · 4 results
- Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice: Comparative Effectiveness of Semaglutide, Dulaglutide, Liraglutide, and Exenatide.
Barkmeier AJ · Ophthalmology. Retina · 2026
Observational study · 18 results
- PIONEER REAL Spain: A multicentre, prospective, real-world study of oral semaglutide use in adults with type 2 diabetes.
Delgado Álvarez E · Diabetes, obesity & metabolism · 2025
Observational study · 10 results
- Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study.
Taipale H · The lancet. Psychiatry · 2026
Observational study · 10 results
- Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus.
Bu F · Journal of the American College of Cardiology · 2026
Observational study · 7 results
- Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.
Taipale H · Acta psychiatrica Scandinavica · 2026
Observational study · 7 results
- Differential Impact of Metabolic Bariatric Surgery Versus Semaglutide on Adverse Hepatic and Extrahepatic Outcomes in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes.
Stupalkowska W · Diabetes, obesity & metabolism · 2026
Observational study · 9 results
- Comparison of Semaglutide and Lifestyle Counselling for Weight Loss Using Multi-Site Electronic Health Records.
Powell WJB · Clinical obesity · 2026
Observational study · 2 results
- Sex specific responses to oral vs. subcutaneous semaglutide in type 2 diabetes mellitus: A 12-month real-world study.
Piccione A · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2026
Observational study · 5 results
- Using real-world data to predict findings of an ongoing phase IV trial: glycemic control of semaglutide versus standard of care.
Kattinakere Sreedhara S · BMJ open diabetes research & care · 2025
Observational study · 2 results
- Comparative Efficacy of Tirzepatide, Liraglutide, and Semaglutide in Reduction of Risk of Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnea and Type 2 Diabetes: Real-World Evidence.
Henney AE · Annals of the American Thoracic Society · 2025
Observational study · 11 results
- Weight loss in people with type 1 diabetes over 12 months: Real-world data comparing tirzepatide, semaglutide and liraglutide.
Al Ozairi E · Diabetes, obesity & metabolism · 2026
Observational study · 17 results
- Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes.
Neumiller JJ · American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
Observational study · 8 results
- Effects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: A 44-week open label prospective study.
Seijas-Amigo J · Diabetes & metabolic syndrome · 2025
Observational study · 9 results
- Early changes in renal function do not appear to mediate cardiovascular risk with dapagliflozin plus semaglutide: a real-world observational hypothesis-generating cohort study.
AlTaweel MO · Expert review of cardiovascular therapy · 2026
Observational study · 3 results
- Target Trial Emulations of GLP-1 and Dual GLP-1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes.
Henney AE · Liver international : official journal of the International Association for the Study of the Liver · 2025
Observational study · 9 results
- Blinded by the drug? A vigilyze signal linking semaglutide to NAION.
Suresh J · International ophthalmology · 2025
Observational study · 5 results
- Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial.
Sklepinski SM · Diabetes research and clinical practice · 2025
Observational study · 14 results
- Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy - a retrospective cohort study.
Aneke-Nash C · BMJ open gastroenterology · 2025
Observational study · 3 results
- Comparative real-world outcomes of tirzepatide vs semaglutide in patients with obesity and type2 diabetes: A retrospective propensity-matched cohort study.
Qadeer A · Diabetes & vascular disease research · 2026
Observational study · 14 results
- Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and formulation-specific risk.
Lakhani M · The British journal of ophthalmology · 2026
Observational study · 5 results
- Real-World Effectiveness of Semaglutide and Tirzepatide Compared With Bariatric Surgery.
Brown A · Obesity (Silver Spring, Md.) · 2026
Observational study · 4 results